Furthermore, Liu et al. [66] showed that a high FoxP3+ Treg/CD8+ T cell ratio is a risk factor for poor response to platinum-based chemotherapy in advanced NSCLC. Here, FOXP3 is linked to non-small cell lung carcinoma.